Global $172.6 Billion Therapies Market for Resistant and Recurrent Metastatic Cancer, 2022

The Global Cancer Therapeutics Market Should Reach $172.6 Billion by 2022 from $121 Billion in 2017 at a CAGR of 7.4%

Report Includes

The Emphasis of this Report is to Provide the Reader With:

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Incidence, Prevalence and Mortality Statistics for Cancer: A Global Summary

4: Metastasis and Current Understanding of the Mechanisms of Resistance and Recurrence in Metastatic Cancer

5: Cancer: Current Therapy Strategies

6: Metastatic Cancer Treatment Options by Tumor Origin

7: Global Market for Cancer Therapeutics by Cancer Type

8: Regulatory and Legislative Requirements

9: Patent Review/ New Developments

10: Company Profiles

11: Company Contact Details

For more information about this report visit https://www.researchandmarkets.com/research/m3k2zj/therapies_for

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716